255 related articles for article (PubMed ID: 9891793)
21. Mutagenesis of NosM Leader Peptide Reveals Important Elements in Nosiheptide Biosynthesis.
Jin L; Wu X; Xue Y; Jin Y; Wang S; Chen Y
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27913416
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
23. Biosynthesis and mode of action of lantibiotics.
Chatterjee C; Paul M; Xie L; van der Donk WA
Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
[No Abstract] [Full Text] [Related]
24. Lantibiotics: how do producers become self-protected?
Alkhatib Z; Abts A; Mavaro A; Schmitt L; Smits SH
J Biotechnol; 2012 Jun; 159(3):145-54. PubMed ID: 22329892
[TBL] [Abstract][Full Text] [Related]
25. Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.
Ongey EL; Neubauer P
Microb Cell Fact; 2016 Jun; 15():97. PubMed ID: 27267232
[TBL] [Abstract][Full Text] [Related]
26. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
27. Lantibiotics: promising candidates for future applications in health care.
Dischinger J; Basi Chipalu S; Bierbaum G
Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
[TBL] [Abstract][Full Text] [Related]
28. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
29. Structure and genetics of circular bacteriocins.
van Belkum MJ; Martin-Visscher LA; Vederas JC
Trends Microbiol; 2011 Aug; 19(8):411-8. PubMed ID: 21664137
[TBL] [Abstract][Full Text] [Related]
30. [Microcins--peptide antibiotics of enterobacteria: genetic control of the synthesis, structure, and mechanism of action].
Khmel' IA
Genetika; 1999 Jan; 35(1):5-16. PubMed ID: 10330606
[TBL] [Abstract][Full Text] [Related]
31. Thiazolyl peptide antibiotic biosynthesis: a cascade of post-translational modifications on ribosomal nascent proteins.
Walsh CT; Acker MG; Bowers AA
J Biol Chem; 2010 Sep; 285(36):27525-31. PubMed ID: 20522549
[TBL] [Abstract][Full Text] [Related]
32. Engineering unusual amino acids into peptides using lantibiotic synthetase.
Nagao J; Shioya K; Harada Y; Okuda K; Zendo T; Nakayama J; Sonomoto K
Methods Mol Biol; 2011; 705():225-36. PubMed ID: 21125389
[TBL] [Abstract][Full Text] [Related]
33. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
34. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
35. Structure and mechanism of lanthipeptide biosynthetic enzymes.
van der Donk WA; Nair SK
Curr Opin Struct Biol; 2014 Dec; 29():58-66. PubMed ID: 25460269
[TBL] [Abstract][Full Text] [Related]
36. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria.
Duquesne S; Petit V; Peduzzi J; Rebuffat S
J Mol Microbiol Biotechnol; 2007; 13(4):200-9. PubMed ID: 17827970
[TBL] [Abstract][Full Text] [Related]
38. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria.
Mainardi JL; Villet R; Bugg TD; Mayer C; Arthur M
FEMS Microbiol Rev; 2008 Mar; 32(2):386-408. PubMed ID: 18266857
[TBL] [Abstract][Full Text] [Related]
39. Genetics of ribosomally synthesized peptide antibiotics.
Kolter R; Moreno F
Annu Rev Microbiol; 1992; 46():141-63. PubMed ID: 1444252
[TBL] [Abstract][Full Text] [Related]
40. Post-translational modifications involved in the biosynthesis of thiopeptide antibiotics.
Zheng Q; Fang H; Liu W
Org Biomol Chem; 2017 Apr; 15(16):3376-3390. PubMed ID: 28358161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
